Evidence map›Paper›PMID 38738241›Full record

ArticleJournal of thoracic disease2024

Etiological diagnostic performance of probe capture-based targeted next-generation sequencing in bloodstream infection.

Sishi Cai, Jianying Yuan, Yingzhen Li, Fengming Guo, Zengshun Lin, Hongyi Li, Qing Miao, Tingting Fang, Yuan Wu, Xiaodong Gao and 4 more

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Clinical characterization ofFrontiers in medicine · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Comparison of molecular testing methods for diagnosing non-tuberculous mycobacterial infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  20. A case report of rapid diagnosis ofFrontiers in medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sishi Cai *Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Jianying Yuan *Guangzhou KingCreate Biotechnology Company Limited, Guangzhou, China.
Yingzhen Li *Guangzhou KingCreate Biotechnology Company Limited, Guangzhou, China.
Fengming GuoGuangzhou KingCreate Biotechnology Company Limited, Guangzhou, China.
Zengshun LinGuangzhou KingCreate Biotechnology Company Limited, Guangzhou, China.
Hongyi LiGuangzhou KingCreate Biotechnology Company Limited, Guangzhou, China.
Qing MiaoDepartment of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Tingting FangDepartment of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Yuan WuDepartment of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiaodong GaoDepartment of Hospital Infection Management, Zhongshan Hospital, Fudan University, Shanghai, China.
Pei LiGuangzhou KingMed Diagnostics Group Company Limited, Guangzhou, China.
Jun LiuGuangzhou KingCreate Biotechnology Company Limited, Guangzhou, China.
Chaohui HuGuangzhou KingCreate Biotechnology Company Limited, Guangzhou, China.
Bijie HuDepartment of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A rapid and precise etiological diagnosis is crucial for the effective treatment of bloodstream infection (BSI). In this study, the performance of probe capture-based targeted next-generation sequencing (tNGS) was compared to that of blood culture and metagenomic next-generation sequencing (mNGS) in detecting potential pathogens in patients with BSI. Methods: A total of 80 patients with suspected BSI were prospectively enrolled from 24 November 2023 to 30 December 2023 at Zhongshan Hospital, Shanghai, China. All 80 participants underwent simultaneous blood culture, blood mNGS, and blood tNGS after admission when febrile, and the results were compared. Results: Among the 80 participants, 11 were clinically diagnosed with noninfectious fever, and 69 were diagnosed with BSI. Blood tNGS had a higher sensitivity for the diagnosis of BSI than blood culture (91.3% Conclusions: Blood tNGS may be a promising tool for detecting potential pathogens in patients with BSI. The application of blood tNGS for BSI could guide anti-infectious treatment strategies and might improve clinical outcomes.

Indexed as

blood culturebloodstream infection (BSI)diagnosticmetagenomic next-generation sequencing (mNGS)Probe capture-based targeted next-generation sequencing (probe capture-based tNGS)

Identifiers

PMID38738241
PMCPMC11087619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.